Healthtech funding in 2017
European Healthtech startup funding raised during 2017.
In 2017, 357 European Healthtech companies closed 384 funding rounds and raised €3.5B in equity funding (excluding debt and grants). Debt rounds added €7.0M. Switzerland led by capital raised, and Bpifrance was the most active investor. Data as of 18 Nov 2026.
Equity funding
€3.5B
excl. debt & grants · +€7.0M debt
Funding rounds
384
Companies
357
Top country
Switzerland
Healthtech: last three years
change vs the year beforeRank among sectors
#3
10.0% of sector funding
Debt financing
€7.0M
0.2% of total
Top-10 round share
43.5%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2017 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €158M | 28 |
| Feb | €62M | 21 |
| Mar | €192M | 30 |
| Apr | €799M | 74 |
| May | €359M | 47 |
| Jun | €195M | 29 |
| Jul | €237M | 47 |
| Aug | €1.1B | 29 |
| Sep | €207M | 36 |
| Oct | €123M | 25 |
| Nov | €123M | 18 |
Top countries
by € raisedHealthtech — top countries by capital, 2017 — interactive chart.
Data table
| Healthtech — top countries by capital, 2017 | |
|---|---|
| Switzerland | €1.2B |
| UK | €540M |
| Israel | €494M |
| France | €464M |
| Sweden | €295M |
| Germany | €212M |
| Spain | €70M |
| Ireland | €54M |
Stage mix
by € raisedHealthtech — stage mix, 2017 — interactive chart.
Data table
| Healthtech — stage mix, 2017 | |
|---|---|
| Other | €1.2B |
| Growth/Late | €1.0B |
| Series A | €424M |
| Series B | €298M |
| Series D+ | €235M |
| Series C | €185M |
| Early VC | €86M |
| Seed | €47M |
| Debt | €7.0M |
| Grant | €3.4M |
Exits & M&A
23 Acquisition · 1 IPO · 1 Merger25 exits · €474M disclosed.
| Zur Rose | IPO | Jan 2017 | €184M |
| Europa Apotheek | Acquisition | Feb 2017 | €126M |
| VisionSense | Acquisition | Oct 2017 | €68M |
| Crospon | Acquisition | May 2017 | €41M |
| iSalud | Acquisition | Sep 2017 | €30M |
| Vitalsana | Acquisition | Oct 2017 | €14M |
Largest equity rounds
by disclosed amount, 2017| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Growth/Late | Aug 2017 | €938M |
| Insightec | Series D+ | Apr 2017 | €140M |
| Bima | Other | Apr 2017 | €91M |
| Biocartis | Other | Apr 2017 | €80M |
| Babylon | Other | Apr 2017 | €56M |
| Simba Sleep | Series B | Apr 2017 | €47M |
| Market Logic | Other | May 2017 | €45M |
| Xeltis | Series C | Apr 2017 | €45M |
| Breath Therapeutics | Series A | Mar 2017 | €44M |
| Nouscom | Series B | Nov 2017 | €42M |
Largest debt rounds
debt financing, 2017; not in the equity total| Company | Stage | Date | Amount |
|---|---|---|---|
| Mauna Kea Technologies | Debt | Feb 2017 | €7.0M |
Top investors
most active in 2017, by deal count- Bpifrance14 deals
- High-Tech Gründerfonds (HTGF)10 deals
- Seventure Partners8 deals
- IDInvest Partners6 deals
- Kurma Partners5 deals
- EQT Ventures4 deals
- Horizon 20204 deals
- Johnson & Johnson4 deals
- Partech Ventures4 deals
- Sofinnova Partners4 deals
Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology